Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum ...

In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized ...

A federal panel of medical experts on Wednesday recommended an expansion of respiratory syncytial virus (RSV) vaccinations for adults and a new combination shot as another option to protect teens ...

A study reveals that Respiratory Syncytial Virus-associated Acute Respiratory Infection increases death risk in adults. The risk is three times higher within a year. RSV can lead to ...

Since the drug is targeting the respiratory system, Strange says the therapy could be used in other disease treatments like pneumonia and Respiratory Syncytial Virus ... what the cycle of the ...

Among the pathogens most closely monitored for their public health impact are respiratory syncytial virus (RSV), influenza viruses, pneumococcal bacteria and SARS-CoV-2. Pneumonia does not ...

About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK ...

I am a 74-year-old man with no major health issues. Over the past several years, I have been getting a COVID booster in the spring with a ...